Last update 12 Apr 2025

Betatinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
TL-512
Target
EGFR
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Advanced Lung Non-Small Cell Carcinoma
Inactive Indication-
Originator Organization
SuZhou Teligene Ltd.SuZhou Teligene Ltd.
Active Organization
SuZhou Teligene Ltd.SuZhou Teligene Ltd.Jinghua Pharmaceutical Group Co., Ltd.Jinghua Pharmaceutical Group Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Betatinib
CTR20171195
/ RecruitingPhase 1
研究观察倍他替尼片在晚期非小细胞肺癌患者中的安全耐受性和药代动力学特征
[Translation] The study observed the safety, tolerability and pharmacokinetic characteristics of betatinib tablets in patients with advanced non-small cell lung cancer
100 Clinical Results associated with Betatinib
Login to view more data
100 Translational Medicine associated with Betatinib
Login to view more data
100 Patents (Medical) associated with Betatinib
Login to view more data
100 Deals associated with Betatinib
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Lung Non-Small Cell CarcinomaPhase 1
China
SuZhou Teligene Ltd.SuZhou Teligene Ltd.
08 Nov 2017
Advanced Lung Non-Small Cell CarcinomaPhase 1
China
Jinghua Pharmaceutical Group Co., Ltd.Jinghua Pharmaceutical Group Co., Ltd.
08 Nov 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free